AMW
Controlled drug delivery for superior treatment. For patients, worldwide.

About AMW
Leader in biodegradable implants for controlled drug delivery
AMW is a specialty pharmaceutical company focused on biodegradable implants, providing patients access to value-added medicines for improved adherence and cost-effective therapies. The Company covers the entire value chain, from (co-)development to manufacturing and international commercialization. AMW has two approved medical products: implants releasing goserelin or leuprorelin respectively, which are distributed worldwide via direct sales and out-licensing.
Management
bmp Ventures Team
Founded
2008
Invested
2013
Stage
Expansion
Industry
Life Sciences & eHealth
Status
Aktiv